Search research articles
Contact Us
Filters
Showing results (31-40 of 137) with videos related to
Page
of 14
Sort By:
Canadian Family Physician Medecin De Famille Canadien
|
August 4, 2012
Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician
Yves Poulin, Norman Wasel, Daphne Chan, et al.
Journal of the American Academy of Dermatology
|
February 15, 2020
Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study
Brian S Kim, Kang Sun, Kim Papp, et al.
Journal of Cutaneous Medicine and Surgery
|
November 6, 2009
Targeting the interleukin-12/23 cytokine family in the treatment of psoriatic disease
Neil H Shear, Jörg Prinz, Kim Papp, et al.
Skin Therapy Letter
|
March 26, 2015
Interleukin-17 (IL-17) inhibitors in the treatment of plaque psoriasis: a review
Melinda Gooderham, Claudia J Posso-De Los Rios, Gustavo A Rubio-Gomez, et al.
Dermatology (Basel, Switzerland)
|
February 5, 2011
Calcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: a randomized, controlled clinical trial
Richard G B Langley, Aditya Gupta, Kim Papp, et al.
Journal of Cutaneous Medicine and Surgery
|
June 27, 2020
Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis
Weiguang Xue, Paranjoy Saharia, Emma Gray, et al.
International Journal of Dermatology
|
July 13, 2010
Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies
Richard G Langley, Kim Papp, Robert Bissonnette, et al.
The Journal of Allergy and Clinical Immunology
|
October 21, 2019
Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream
Brian S Kim, Michael D Howell, Kang Sun, et al.
Journal of Drugs in Dermatology : JDD
|
September 16, 2017
Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study
Linda Stein Gold, Kim Papp, Charles Lynde, et al.
Cutis
|
April 30, 2008
Efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris in adolescents
Sharon Raimer, J Michael Maloney, Marc Bourcier, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 137) with videos related to
Sort By:
Page
of 14
Canadian Family Physician Medecin De Famille Canadien
|
August 4, 2012
Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician
Yves Poulin, Norman Wasel, Daphne Chan, et al.
Journal of the American Academy of Dermatology
|
February 15, 2020
Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study
Brian S Kim, Kang Sun, Kim Papp, et al.
Journal of Cutaneous Medicine and Surgery
|
November 6, 2009
Targeting the interleukin-12/23 cytokine family in the treatment of psoriatic disease
Neil H Shear, Jörg Prinz, Kim Papp, et al.
Skin Therapy Letter
|
March 26, 2015
Interleukin-17 (IL-17) inhibitors in the treatment of plaque psoriasis: a review
Melinda Gooderham, Claudia J Posso-De Los Rios, Gustavo A Rubio-Gomez, et al.
Dermatology (Basel, Switzerland)
|
February 5, 2011
Calcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: a randomized, controlled clinical trial
Richard G B Langley, Aditya Gupta, Kim Papp, et al.
Journal of Cutaneous Medicine and Surgery
|
June 27, 2020
Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis
Weiguang Xue, Paranjoy Saharia, Emma Gray, et al.
International Journal of Dermatology
|
July 13, 2010
Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies
Richard G Langley, Kim Papp, Robert Bissonnette, et al.
The Journal of Allergy and Clinical Immunology
|
October 21, 2019
Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream
Brian S Kim, Michael D Howell, Kang Sun, et al.
Journal of Drugs in Dermatology : JDD
|
September 16, 2017
Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study
Linda Stein Gold, Kim Papp, Charles Lynde, et al.
Cutis
|
April 30, 2008
Efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris in adolescents
Sharon Raimer, J Michael Maloney, Marc Bourcier, et al.
Page
of 14